Nordea Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
8,824
+1,196
| +16% | +$151K | ﹤0.01% | 807 |
|
|
2025
Q1 | $850K | Buy |
7,628
+30
| +0.4% | +$3.34K | ﹤0.01% | 827 |
|
|
2024
Q4 | $1.04M | Hold |
7,598
| – | – | ﹤0.01% | 800 |
|
|
2024
Q3 | $875K | Sell |
7,598
-20,344
| -73% | -$2.34M | ﹤0.01% | 822 |
|
|
2024
Q2 | $3.84M | Buy |
27,942
+1,259
| +5% | +$173K | ﹤0.01% | 581 |
|
|
2024
Q1 | $3.68M | Sell |
26,683
-65
| -0.2% | -$8.96K | ﹤0.01% | 601 |
|
|
2023
Q4 | $3.54M | Sell |
26,748
-1,843
| -6% | -$244K | ﹤0.01% | 607 |
|
|
2023
Q3 | $3.28M | Buy |
28,591
+19,238
| +206% | +$2.21M | ﹤0.01% | 607 |
|
|
2023
Q2 | $890K | Sell |
9,353
-419
| -4% | -$39.9K | ﹤0.01% | 834 |
|
|
2023
Q1 | $966K | Sell |
9,772
-3,174
| -25% | -$314K | ﹤0.01% | 795 |
|
|
2022
Q4 | $1.54M | Sell |
12,946
-7,115
| -35% | -$847K | ﹤0.01% | 703 |
|
|
2022
Q3 | $2.1M | Sell |
20,061
-357,598
| -95% | -$37.3M | ﹤0.01% | 675 |
|
|
2022
Q2 | $36.5M | Sell |
377,659
-142,851
| -27% | -$13.8M | 0.05% | 242 |
|
|
2022
Q1 | $48.6M | Sell |
520,510
-38,694
| -7% | -$3.61M | 0.06% | 243 |
|
|
2021
Q4 | $47.6M | Buy |
559,204
+96,375
| +21% | +$8.21M | 0.06% | 252 |
|
|
2021
Q3 | $44.1M | Buy |
462,829
+80,143
| +21% | +$7.64M | 0.06% | 263 |
|
|
2021
Q2 | $37.2M | Buy |
382,686
+191,140
| +100% | +$18.6M | 0.05% | 277 |
|
|
2021
Q1 | $18.6M | Buy |
191,546
+33,344
| +21% | +$3.24M | 0.03% | 318 |
|
|
2020
Q4 | $15.2M | Buy |
158,202
+48,738
| +45% | +$4.67M | 0.02% | 325 |
|
|
2020
Q3 | $10.8M | Sell |
109,464
-86,846
| -44% | -$8.54M | 0.02% | 325 |
|
|
2020
Q2 | $24.6M | Buy |
196,310
+110,724
| +129% | +$13.9M | 0.03% | 304 |
|
|
2020
Q1 | $7.76M | Buy |
85,586
+9,452
| +12% | +$857K | 0.02% | 348 |
|
|
2019
Q4 | $8.16M | Sell |
76,134
-61,347
| -45% | -$6.57M | 0.02% | 358 |
|
|
2019
Q3 | $12.3M | Buy |
137,481
+83,777
| +156% | +$7.52M | 0.03% | 319 |
|
|
2019
Q2 | $4.54M | Buy |
53,704
+14,708
| +38% | +$1.24M | 0.01% | 531 |
|
|
2019
Q1 | $3.44M | Buy |
38,996
+465
| +1% | +$41K | 0.01% | 756 |
|
|
2018
Q4 | $2.75M | Hold |
38,531
| – | – | 0.01% | 775 |
|
|
2018
Q3 | $4.74M | Buy |
38,531
+5,939
| +18% | +$730K | 0.01% | 591 |
|
|
2018
Q2 | $3.2M | Sell |
32,592
-4,243
| -12% | -$417K | 0.01% | 599 |
|
|
2018
Q1 | $3.06M | Buy |
36,835
+3,284
| +10% | +$272K | 0.01% | 596 |
|
|
2017
Q4 | $2.6M | Sell |
33,551
-6,096
| -15% | -$473K | 0.01% | 560 |
|
|
2017
Q3 | $2.43M | Sell |
39,647
-1,585
| -4% | -$97.1K | 0.01% | 560 |
|
|
2017
Q2 | $1.9M | Buy |
+41,232
| New | +$1.9M | ﹤0.01% | 645 |
|